Healthcare

The medical technology giant Stryker delivered impressive third-quarter financial results, yet its stock is experiencing a puzzling decline. While the...

The telehealth company Hims & Hers Health has seen its share price collapse by 30% over the past month, a...

DexCom finds itself at a pivotal moment as conflicting developments create uncertainty for investors. The continuous glucose monitoring leader faces...

Viking Therapeutics has achieved a significant advancement in its obesity treatment program, completing patient enrollment for its pivotal Phase 3...

The telehealth sector is facing significant headwinds, and Hims & Hers finds itself at a critical juncture. The company is...

UnitedHealth Group, the nation's largest provider of Medicare plans, is navigating a severe operational storm. The company is contending with...

A patient death in a key study has triggered a severe downturn for Intellia Therapeutics, with the gene-editing company's stock...

The telehealth provider Hims & Hers finds itself navigating turbulent market conditions. Despite management's confident move to authorize a substantial...

ResMed's latest quarterly earnings have painted a complex picture for investors. The medical technology specialist delivered fundamentally strong results, yet...

UnitedHealth Group's recent appointment of former FDA commissioner Scott Gottlieb to its board of directors has generated a surprising market...